Novo-Veramil en es it fr

Novo-Veramil Brand names, Novo-Veramil Analogs

Novo-Veramil Brand Names Mixture

  • Tarka (trandolapril + verapamil hydrochloride)

Novo-Veramil Chemical_Formula


Novo-Veramil RX_link

Novo-Veramil fda sheet

Novo-Veramil FDA

Novo-Veramil msds (material safety sheet)

Novo-Veramil Synthesis Reference

Dengel, U.S. Pat. 3,261,859 (1966)

Novo-Veramil Molecular Weight

454.602 g/mol

Novo-Veramil Melting Point

< 25 oC

Novo-Veramil H2O Solubility

4.47 mg/L

Novo-Veramil State


Novo-Veramil LogP


Novo-Veramil Dosage Forms

Capsule (sustained-release); Liquid; Solution; Tablet; Tablet (extended-release)

Novo-Veramil Indication

For the treatment of hypertension and angina.

Novo-Veramil Pharmacology

Verapamil, a class IV antiarrhythmic agent, is used as a calcium-channel blocking (CCB) agent for the treatment of angina, hypertension, and for supraventricular tachyarrhythmias.

Novo-Veramil Absorption


Novo-Veramil side effects and Toxicity

LD50=8 mg/kg (i.v. in mice)

Novo-Veramil Patient Information

Verapamil HCl is known as a calcium channel blocker. It is taken to treat high blood pressure, to relieve some chest pains in patients with angina, or to treat some problems with heart rhythms. Verapamil has several drug interactions, make sure your physician and pharmacist known all the medicines you are taking so they may properly advise you. Verapamil HCl is excreted in breast milk. It may be necessary to change therapy or provide an alternate to breast milk. The most common side effect is constipation. This may be relieved with dietary modification (more fiber) or laxatives. Sustained release tablets should be taken with food. They should not be broken or crushed. Doses may need some adjustment, make sure to have your condition monitored regularly.

Novo-Veramil Organisms Affected

Humans and other mammals